Jasper Therapeutics announces 1-for-30 reverse stock split
JSPR•Jasper Therapeutics will implement a 1-for-30 reverse stock split effective November 6, 2026. Outstanding common shares will decline to approximately 1,110,000 from 33,300,000, subject to fractional-share adjustments.
1. Split details
The split-adjusted shares will begin trading on the Nasdaq Capital Market at the November 6 market open under the unchanged symbol JSPR. No fractional shares will be issued; cash payments will reflect the November 5 closing share price.
